Log In
Thursday 27th June 2019

Avastin 'not approved' for breast cancers

24th February 2011

The National Institute for health and Clinical Excellence (NICE) has ruled that the drug Avastin should not be used to treat secondary breast cancers.

The NHS drugs advisory body for NHS in England and Wales said there was insufficient evidence that the drug prolonged life, though breast cancer charities have said that they are disappointed by the decision. Avastin, also known as bevacizumab, works by starving cancer cells of a blood supply and is designed to be used in conjunction with another chemotherapy drug, paclitaxel.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

M3 - For secure managed hosting over N3 or internet
© Mayden Foundation 2019